Centre writes to states over ‘blatant’ Covid norms violation

New Delhi: The home ministry has written to all states and Union Territories expressing concern over “blatant violation” of Covid norms in several parts of the country and consequent increase in “R” factor (reproduction number) in some states.

The home secretary has asked states to issue strict directions to the local authorities to regulate crowded places, take action against violators as per law and ensure that concerned authorities and officials are held accountable in case of any laxity in enforcement of Covid appropriate behaviour.

The MHA expressed special concern over crowds violating norms in hill stations and market places. In his letter, home secretary Ajay Bhalla said while with the decline in number of active case, states and UTs have started ‘unlocking’ in a gradual manner, the process should be carefully calibrated. He also cited the June 29 order by the MHA for implementation of targeted and prompt actions for Covid-19 management.

“However, blatant violations of Covid norms have been observed in several parts of country, especially in public transport and at hill stations. Massive crowds are also thronging the market places, violating norms of social distancing. Consequently increase in R factor (reproduction number) in some of the states is a matter of concern,” he said. The letter emphasised that the second wave of Covid is not yet over.

The MHA said that states must be aware any increase in R factor above 1.0 is an indicator of the spread of Covid-19.

“Therefore, it is important that the authorities concerned shall be responsible for ensuring Covid appropriate behaviour in all crowded places, such markets, restaurants, bus stations, railway platforms, public parks, banquet and marriage halls, sports complexes and all areas identified as hotspots for transmission of the virus,” Bhalla said.

  • Related Posts

    4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

    Meerut: A four-year-old boy’s condition allegedly worsened after he was administered an anti-rabies injection at Sambhal district hospital following a snakebite. A pharmacist at the hospital has been removed from…

    Lupin gets tentative US FDA nod for apixaban oral suspension for patients who cannot swallow tablets

    Once final approval comes through, the liquid anticoagulant will be made at Lupin’s plant in Somerset, New Jersey, the company said. Mumbai: Lupin has received tentative approval from the US…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

    4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

    Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

    Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

    Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

    Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

    Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

    Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

    Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

    Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

    Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore

    Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore